Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial

Blood. 2020 Jan 16;135(3):227-229. doi: 10.1182/blood.2019000358.

Régis Peffault de Latour^{1

2}, Sylvie Chevret^{2

3}, Anna Lisa Ruggeri^{4

5}, Felipe Suarez⁶, Laetitia Souchet⁷, David Michonneau¹, Flore Sicre de Fontbrune¹, Tereza Coman¹, Nathalie Dhedin¹, Marie Thérèse Rubio^{8

9}, Stéphanie Nguyen^{7

8

9}, Mohamad Mohty^{4

8

9

10}, Gérard Socié^{1

2}

¹ Bone Marrow Transplantation Unit, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
² Université de Paris, Paris, France.
³ Biostatistic Unit, Saint Louis Hospital and.
⁴ Hematology and Cell Therapy Unit, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
⁵ Department of Pediatric Hematology and Oncology, Istituto Di Ricovero e Cura a Carattere Scientifico, Bambino Gesu Pediatric Hospital, Rome, Italy.
⁶ Bone Marrow Transplantation Unit, Necker Hospital and.
⁷ Bone Marrow Transplantation Unit, Pitié Salpetrière Hospital, Assistance Publique Hôpitaux de Paris, Paris.
⁸ Hematology Department, Bone Marrow Transplantation Unit, Nancy, France.
⁹ Sorbonne Université, Paris, France; and.
¹⁰ INSERM Unite Mixte de Recherche 938, Paris, France.

No abstract available

Publication types